Expression profiling of cell cycle genes in human pancreatic islets with and without type 2 diabetes

Molecular and Cellular Endocrinology

Volumn 375, Issue 1-2, 2013, Pages 35-42

  Taneera, Jalal ^a   Fadista, Joao ^a   Ahlqvist, Emma ^a   Zhang, Mengze ^a   Wierup, Nils ^a   Renström, Erik ^a   Groop, Leif ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Beta cell; Cell cycle; Cyclin; Human islet; Microarray; Type 2 diabetes

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 3; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 8; CYCLIN DEPENDENT KINASE 9; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN I; CYCLINE; HEMOGLOBIN A1C;

ADULT; AGE; ARTICLE; CCND1 GENE; CCNI GENE; CDK1 GENE; CDK16 GENE; CDK18 GENE; CDK3 GENE; CDK8 GENE; CDK9 GENE; CDKN1A GENE; CDKN2A GENE; CDNI2 GENE; CLINICAL ARTICLE; CONTROLLED STUDY; CYCLIN DEPENDENT KINASE GENE; CYCLIN DEPENDENT KINASE INHIBITOR GENE; CYCLIN GENE; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; INSULIN RELEASE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; AGING; CASE-CONTROL STUDIES; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR PROTEINS; CYCLIN-DEPENDENT KINASES; CYCLINS; DIABETES MELLITUS, TYPE 2; FEMALE; GENE EXPRESSION PROFILING; GENES, CDC; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INSULIN; ISLETS OF LANGERHANS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSCRIPTOME;

EID: 84878699515     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2013.05.003     Document Type: Article

References (46)

1. Brinkkoetter P.T., Pippin J.W., Shankland S.J. Cyclin I-Cdk5 governs survival in post-mitotic cells. Cell Cycle 2010, 9:1729-1731.
2. Chen H., et al. Polycomb protein Ezh2 regulates pancreatic beta-cell Ink4a/Arf expression and regeneration in diabetes mellitus. Genes Dev. 2009, 23:975-985.
3. Cozar-Castellano I., Takane K.K., Bottino R., Balamurugan A.N., Stewart A.F. Induction of beta-cell proliferation and retinoblastoma protein phosphorylation in rat and human islets using adenovirus-mediated transfer of cyclin-dependent kinase-4 and cyclin D1. Diabetes 2004, 53:149-159.
4. Cozar-Castellano I., et al. Molecular control of cell cycle progression in the pancreatic beta-cell. Endocr. Rev. 2006, 27:356-370.
5. Dor Y., Brown J., Martinez O.I., Melton D.A. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 2004, 429:41-46.
6. Fiaschi-Taesch N., et al. Survey of the human pancreatic beta-cell G1/S proteome reveals a potential therapeutic role for cdk-6 and cyclin D1 in enhancing human beta-cell replication and function in vivo. Diabetes 2009, 58:882-893.
7. Fiaschi-Taesch N.M., et al. Induction of human beta-cell proliferation and engraftment using a single G1/S regulatory molecule, cdk6. Diabetes 2010, 59:1926-1936.
8. Firestein R., et al. CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity. Nature 2008, 455:547-551.
9. Franklin D.S., Godfrey V.L., O'Brien D.A., Deng C., Xiong Y. Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity. Mol. Cell Biol. 2000, 20:6147-6158.
10. Georgia S., Bhushan A. Beta cell replication is the primary mechanism for maintaining postnatal beta cell mass. J. Clin. Invest. 2004, 114:963-968.
11. Georgia S., et al. Cyclin D2 is essential for the compensatory beta-cell hyperplastic response to insulin resistance in rodents. Diabetes 2010, 59:987-996.
12. Halban P.A. Cellular sources of new pancreatic beta cells and therapeutic implications for regenerative medicine. Nat. Cell Biol. 2004, 6:1021-1025.
13. Harb G., Vasavada R.C., Cobrinik D., Stewart A.F. The retinoblastoma protein and its homolog p130 regulate the G1/S transition in pancreatic beta-cells. Diabetes 2009, 58:1852-1862.
14. He L.M., et al. Cyclin D2 protein stability is regulated in pancreatic beta-cells. Mol. Endocrinol. 2009, 23:1865-1875.
15. Heit J.J., Karnik S.K., Kim S.K. Intrinsic regulators of pancreatic beta-cell proliferation. Annu. Rev. Cell Dev. Biol. 2006, 22:311-338.
16. Hinault C., Hu J., Maier B.F., Mirmira R.G., Kulkarni R.N. Differential expression of cell cycle proteins during ageing of pancreatic islet cells. Diabetes Obes. Metab. 2008, 10(Suppl. 4):136-146.
17. Iankova I., et al. Peroxisome proliferator-activated receptor gamma recruits the positive transcription elongation factor b complex to activate transcription and promote adipogenesis. Mol. Endocrinol. 2006, 20:1494-1505.
18. Inouye M., et al. PLoS Genet. 2010, 6.
19. Kahn S.E. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 2003, 46:3-19.
20. Kamijo T., et al. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 1997, 91:649-659.
21. Kaneto H., et al. Oxidative stress induces p21 expression in pancreatic islet cells: possible implication in beta-cell dysfunction. Diabetologia 1999, 42:1093-1097.
22. Karnik S.K., et al. Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c. Proc. Natl. Acad. Sci. USA 2005, 102:14659-14664.
23. Krishnamurthy J., et al. Ink4a/Arf expression is a biomarker of aging. J. Clin. Invest. 2004, 114:1299-1307.
24. Krishnamurthy J., et al. P16INK4a induces an age-dependent decline in islet regenerative potential. Nature 2006, 443:453-457.
25. Kushner J.A., et al. Cyclins D2 and D1 are essential for postnatal pancreatic beta-cell growth. Mol. Cell Biol. 2005, 25:3752-3762.
26. Landberg G., et al. Cyclin I is expressed in human breast cancer and closely associated with VEGF and KDR expression. Breast Cancer Res. Treat. 2005, 89:313-316.
27. Lee S.H., et al. Islet specific Wnt activation in human type II diabetes. Exp. Diabetes Res. 2008, 2008:728763.
28. Marselli L., et al. Gene expression profiles of Beta-cell enriched tissue obtained by laser capture microdissection from subjects with type 2 diabetes. PLoS One 2010, 5:e11499.
29. Meier J.J., et al. Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta-cell mass in humans. Diabetes 2008, 57:1584-1594.
30. Minamino T., et al. A crucial role for adipose tissue p53 in the regulation of insulin resistance. Nat. Med. 2009, 15:1082-1087.
31. Miyatsuka T., Kosaka Y., Kim H., German M.S. Neurogenin3 inhibits proliferation in endocrine progenitors by inducing Cdkn1a. Proc. Natl. Acad. Sci. USA 2011, 108:185-190.
32. Nakamura T., et al. Cyclin I: a new cyclin encoded by a gene isolated from human brain. Exp. Cell Res. 1995, 221:534-542.
33. Perl S., et al. Significant human beta-cell turnover is limited to the first three decades of life as determined by in vivo thymidine analog incorporation and radiocarbon dating. J. Clin. Endocrinol. Metab. 2010, 95:E234-9.
34. Rane S.G., et al. Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia. Nat. Genet. 1999, 22:44-52.
35. Reers C., et al. Impaired islet turnover in human donor pancreata with aging. Eur. J. Endocrinol. 2009, 160:185-191.
36. Riva M., et al. Nesfatin-1 stimulates glucagon and insulin secretion and beta cell NUCB2 is reduced in human type 2 diabetic subjects. Cell Tissue Res. 2011, 346:393-405.
37. Sano M., Schneider M.D. Cyclins that don't cycle-cyclin T/cyclin-dependent kinase-9 determines cardiac muscle cell size. Cell Cycle 2003, 2:99-104.
38. Santamaria D., et al. Cdk1 is sufficient to drive the mammalian cell cycle. Nature 2007, 448:811-815.
39. Stein J., Milewski W.M., Hara M., Steiner D.F., Dey A. GSK-3 inactivation or depletion promotes beta-cell replication via down regulation of the CDK inhibitor, p27 (Kip1). Islets 2011, 3:21-34.
40. Sun Z.L., et al. Serum proteomic-based analysis of pancreatic carcinoma for the identification of potential cancer biomarkers. Biochim. Biophys. Acta 2007, 1774:764-771.
41. Taneera J., et al. A systems genetics approach identifies genes and pathways for type 2 diabetes in human islets. Cell. Metab. 2012, 16:122-134.
42. Uchida T., et al. Deletion of Cdkn1b ameliorates hyperglycemia by maintaining compensatory hyperinsulinemia in diabetic mice. Nat. Med. 2005, 11:175-182.
43. Voight B.F., et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat. Genet. 2010, 42:579-589.
44. Zhao Z., Choi J., Zhao C., Ma Z.A. FTY720 normalizes hyperglycemia by stimulating beta-cell in vivo regeneration in db/db mice through regulation of cyclin D3 and p57(KIP2). J. Biol. Chem. 2012, 287:5562-5573.
45. Zhou Q., Yik J.H. The Yin and Yang of P-TEFb regulation: implications for human immunodeficiency virus gene expression and global control of cell growth and differentiation. Microbiol. Mol. Biol. Rev. 2006, 70:646-659.
46. Zhu X., Naz R.K. Expression of a novel isoform of cyclin I in human testis. Biochem. Biophys. Res. Commun. 1998, 249:56-60.